Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/datopotamab-deruxtecan-earns-new-breast-cancer-indication-2026a1000gti
via IFTTT

‘Swap to Stop’ Vape Scheme Aids Smoking Cessation in England

An early evaluation of ‘Swap to Stop’ scheme in England shows a 4-week quit rate of 34.3% among recipients of free e-cigarette starter kits, with an estimated product cost per 4-week quit of £113.17.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/swap-stop-vape-scheme-aids-smoking-cessation-england-2026a1000gff
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started